| Mrs Tracey Anne Buffum, MED | |
|
140 Point Judith Rd, Unit 44, J. Trudeau Memorial Center, Narragansett, RI 02882-3451 | |
| (401) 783-6853 | |
| Not Available |
| Full Name | Mrs Tracey Anne Buffum |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 140 Point Judith Rd, Narragansett, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275733479 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SP00941 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Tracey Anne Buffum, MED 20 Greenbriar Pl, Kingston, RI 02881-1733 Ph: (401) 284-3680 | Mrs Tracey Anne Buffum, MED 140 Point Judith Rd, Unit 44, J. Trudeau Memorial Center, Narragansett, RI 02882-3451 Ph: (401) 783-6853 |
News Archive
Cell Therapeutics, Inc. today announced the initiation of an international cooperative group Phase 2 clinical trial of pacritinib in adult patients with relapsed acute myeloid leukemia (AML) with mutations of the FLT3 gene. Mutation of the FLT3 gene is found in approximately one-third of AML patients and is an independent risk factor for poor prognosis.
TaiGen Biotechnology Company, Limited today announced that together with its distribution partner, Holding Distribution, it has launched Taigexyn (nemonoxacin) capsules in Taiwan, the first market where Taigexyn is available.
As the 64th World Health Assembly gets underway in Geneva, the body will consider "an array of subjects pertaining to reforms of the organisation and its financing, vaccines, fake medicines, and influenza pandemic preparedness, as well as communicable and non-communicable diseases," Intellectual Property Watch reports.
The state of Kansas' largest insurance company has decided it doesn't want to participate in Gov. Sam Brownback's plan to move Medicaid patients into privatized managed-care programs. In a letter addressed "Dear provider," Angie Strecker, director of institutional relations for Blue Cross Blue Shield of Kansas, said the insurer "has decided not to submit a proposal to the state to be a Medicaid contractor."
› Verified 5 days ago
Ms. Elizabeth Ann Lavoie, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 50 S Bay Dr # 17, Narragansett, RI 02882 Phone: 401-783-6664 | |
Eve Evans Sadd, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 115 Secluded Dr, Narragansett, RI 02882 Phone: 401-742-3033 | |
Mrs. Gloria Gemma Figueroa, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 17 Talia Ct, Narragansett, RI 02882 Phone: 401-284-1122 | |
Gabrielle Leclerc, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 27 Orlando Dr, Narragansett, RI 02882 Phone: 401-932-7590 | |
Kirsten A O'neill, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14 Woodruff Ave, Suite 7, Narragansett, RI 02882 Phone: 401-782-0500 Fax: 401-788-2253 | |
Jill N Fallon, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14 Woodruff Ave, Suite 7, Narragansett, RI 02882 Phone: 401-782-0500 Fax: 401-788-2253 |